found oral semaglutide HUGE news in the GLP-1 space! Orforglipron has outperformed in the ACHIEVE-3 clinical trial in patients with type 2 diabetes. Comment your thoughts below! ⬇️ This compounded medication has not been approved by the FDA for these uses New GLP-1 Outperforms Oral Semaglutide
Pay in 4 interest-free payments of $6.81 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6



























